$MNTS
Momentus Inc. Stock $mnts

$mnts Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000178116222000107 Filed on November 09, 2022

Income Statement

Concept	2022 Q4	2022 Q3
Revenue	$120.0K	$129.0K
YoY Change		-35.5%
Cost Of Revenue	$0.00	$14.00K
YoY Change		-107.61%
Gross Profit	$120.0K	$115.0K
YoY Change		-70.05%
Gross Profit Margin	100.0%	89.15%
Selling, General & Admin	$10.93M	$11.18M
YoY Change	-16.59%	-7.24%
% of Gross Profit	9107.5%	9725.22%
Research & Development	$10.28M	$10.57M
YoY Change	-11.15%	16.85%
% of Gross Profit	8569.17%	9192.17%
Depreciation & Amortization	$259.0K	$200.0K
YoY Change	-20.06%	-33.33%
% of Gross Profit	215.83%	173.91%
Operating Expenses	$21.21M	$21.76M
YoY Change	-14.04%	3.08%
Operating Profit	-$21.09M	-$21.64M
YoY Change		4.44%
Interest Expense	-$607.0K	$1.261M
YoY Change		-70.86%
% of Operating Profit
Other Income/Expense, Net	$1.813M	$342.0K
YoY Change	-93.41%	-97.74%
Pretax Income	-$24.44M	-$21.30M
YoY Change	795.57%	279.37%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$24.44M	-$21.30M
YoY Change	795.24%	279.37%
Net Earnings / Revenue	-20366.67%	-16510.08%
Basic Earnings Per Share		-$0.26
Diluted Earnings Per Share	-$0.30	-$0.26
COMMON SHARES
Basic Shares Outstanding	84.15M shares	83.28M shares
Diluted Shares Outstanding		82.07M shares

Balance Sheet

Concept	2022 Q4	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$61.09M	$81.57M
YoY Change	-61.82%	-54.4%
Cash & Equivalents	$61.09M	$81.57M
Short-Term Investments
Other Short-Term Assets	$11.18M	$11.23M
YoY Change	16.12%	7.86%
Inventory
Prepaid Expenses
Receivables	$0.00
Other Receivables
Total Short-Term Assets	$76.27M	$92.80M
YoY Change	-55.04%	-50.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.016M	$4.333M
YoY Change	-16.84%	-9.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.712M	$3.894M
YoY Change	53.74%	27.05%
Total Long-Term Assets	$16.15M	$15.90M
YoY Change	-0.07%	-2.75%
TOTAL ASSETS
Total Short-Term Assets	$76.27M	$92.80M
Total Long-Term Assets	$16.15M	$15.90M
Total Assets	$92.42M	$108.7M
YoY Change	-50.26%	-47.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.239M	$1.596M
YoY Change	17.16%	-66.44%
Accrued Expenses	$8.026M	$7.881M
YoY Change	-17.98%	17.05%
Deferred Revenue	$1.654M	$1.226M
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$11.63M	$10.84M
YoY Change	-44.39%	-38.43%
Total Short-Term Liabilities	$43.23M	$32.80M
YoY Change	11.22%	-7.12%
LONG-TERM LIABILITIES
Long-Term Debt	$2.404M	$5.583M
YoY Change
Other Long-Term Liabilities	$465.0K	$459.0K
YoY Change	-3.73%	5.03%
Total Long-Term Liabilities	$10.59M	$16.01M
YoY Change	-29.73%	3564.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$43.23M	$32.80M
Total Long-Term Liabilities	$10.59M	$16.01M
Total Liabilities	$53.82M	$48.81M
YoY Change	-0.22%	-37.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$304.1M	-$279.7M
YoY Change	45.74%	35.8%
Common Stock	$1.000K	$1.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$38.61M	$59.89M
YoY Change
Total Liabilities & Shareholders Equity	$92.42M	$108.7M
YoY Change	-50.26%	-47.14%

Cashflow Statement

Concept	2022 Q4	2022 Q3
OPERATING ACTIVITIES
Net Income	-$24.44M	-$21.30M
YoY Change	795.24%	279.37%
Depreciation, Depletion And Amortization	$259.0K	$200.0K
YoY Change	-20.06%	-33.33%
Cash From Operating Activities	-$16.39M	-$25.55M
YoY Change	12.4%	-8.91%
INVESTING ACTIVITIES
Capital Expenditures	$119.0K	$304.0K
YoY Change	-149.79%	-145.85%
Acquisitions
YoY Change
Other Investing Activities	$27.00K	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$92.00K	$304.0K
YoY Change	-61.34%	-145.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.270M	-2.967M
YoY Change	-14.49%	-101.7%
NET CHANGE
Cash From Operating Activities	-16.39M	-25.55M
Cash From Investing Activities	-92.00K	304.0K
Cash From Financing Activities	-3.270M	-2.967M
Net Change In Cash	-19.75M	-28.22M
YoY Change	5.95%	-119.3%
FREE CASH FLOW
Cash From Operating Activities	-$16.39M	-$25.55M
Capital Expenditures	$119.0K	$304.0K
Free Cash Flow	-$16.51M	-$25.86M
YoY Change	15.11%	-5.6%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001781162
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
CY2021Q3	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2022#ServiceMember
CY2022Q3	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2022#ServiceMember
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2022#ServiceMember
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2022#ServiceMember
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39128
	dei	Entity Registrant Name EntityRegistrantName	Momentus Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1905538
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3901 N. First Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Jose
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95134
	dei	City Area Code CityAreaCode	650
	dei	Local Phone Number LocalPhoneNumber	564-7820
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	84149721	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	81570000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	160036000	usd
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	287000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	197000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10939000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9431000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	92796000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	169664000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4333000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4829000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	343000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	349000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6715000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7604000	usd
CY2022Q3	us-gaap	Deferred Costs DeferredCosts	309000	usd
CY2021Q4	us-gaap	Deferred Costs DeferredCosts	0	usd
CY2022Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	310000	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	314000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3894000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3065000	usd
CY2022Q3	us-gaap	Assets Assets	108700000	usd
CY2021Q4	us-gaap	Assets Assets	185825000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1596000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1911000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7881000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9785000	usd
CY2022Q3	us-gaap	Loans Payable Current LoansPayableCurrent	10844000	usd
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	20907000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1226000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1140000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1189000	usd
CY2022Q3	mnts	Share Repurchase Liability Current ShareRepurchaseLiabilityCurrent	10000000	usd
CY2021Q4	mnts	Share Repurchase Liability Current ShareRepurchaseLiabilityCurrent	0	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	110000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5075000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	32797000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	38867000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1178000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1554000	usd
CY2022Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	5583000	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	0	usd
CY2022Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2367000	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5749000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6425000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7284000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	459000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	483000	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	16012000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	15070000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	48809000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	53937000	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	83984571	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	83984571	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81211781	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81211781	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	339576000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	340570000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-279686000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-208683000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	59891000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	131888000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	108700000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	185825000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	129000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	200000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	179000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	330000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14000	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	-184000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	26000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	-135000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	115000	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	384000	usd
	us-gaap	Gross Profit GrossProfit	153000	usd
	us-gaap	Gross Profit GrossProfit	465000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10571000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9047000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31438000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39747000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11184000	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12057000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	38898000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	35802000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	21755000	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	21104000	usd
	us-gaap	Operating Expenses OperatingExpenses	70336000	usd
	us-gaap	Operating Expenses OperatingExpenses	75549000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-21640000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-20721000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-70183000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-75084000	usd
CY2022Q3	mnts	Fair Value Adjustment To Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentToFinancialInstrumentsSubjectToMandatoryRedemption	0	usd
CY2021Q3	mnts	Fair Value Adjustment To Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentToFinancialInstrumentsSubjectToMandatoryRedemption	26924000	usd
	mnts	Fair Value Adjustment To Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentToFinancialInstrumentsSubjectToMandatoryRedemption	0	usd
	mnts	Fair Value Adjustment To Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentToFinancialInstrumentsSubjectToMandatoryRedemption	209291000	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1579000	usd
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2712000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3382000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-9826000	usd
CY2022Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-45000	usd
CY2021Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-114000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	28000	usd
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	33000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	1261000	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	4328000	usd
	us-gaap	Interest Expense InterestExpense	4166000	usd
	us-gaap	Interest Expense InterestExpense	8685000	usd
CY2022Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
CY2021Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-7000000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	41000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4778000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	44000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4965000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	342000	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	15107000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-821000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	198469000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21298000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5614000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-71004000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	123385000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-21298000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-5614000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-71004000	usd
	us-gaap	Net Income Loss NetIncomeLoss	123384000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.88
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.06
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.88
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.92
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82066795	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60589566	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81122541	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59873199	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82066795	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60589566	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81122541	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64232537	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	131888000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	48000	usd
CY2022Q1	mnts	Stock Issued During Period Value Section16 Officer Tax Coverage Exchange StockIssuedDuringPeriodValueSection16OfficerTaxCoverageExchange	59000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2212000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-6000000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-26834000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	101255000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	345000	usd
CY2022Q2	mnts	Stock Issued During Period Purchase Of Employee Share Purchase Plan StockIssuedDuringPeriodPurchaseOfEmployeeSharePurchasePlan	190000	usd
CY2022Q2	mnts	Stock Issued During Period Value Section16 Officer Tax Coverage Exchange StockIssuedDuringPeriodValueSection16OfficerTaxCoverageExchange	38000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3105000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	220000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-22872000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	82205000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	125000	usd
CY2022Q3	mnts	Stock Issued During Period Value Section16 Officer Tax Coverage Exchange StockIssuedDuringPeriodValueSection16OfficerTaxCoverageExchange	168000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3247000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-4220000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-21298000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	59891000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-289472000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	24000	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5768000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	64671000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-219009000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2344000	usd
CY2021Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	22000000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	64327000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-174326000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	245000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3075000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	6999000	usd
CY2021Q3	mnts	Stock Issued During Period Value Conversion Of Safe Notes StockIssuedDuringPeriodValueConversionOfSAFENotes	136001000	usd
CY2021Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	18000000	usd
CY2021Q3	mnts	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	75114000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	104022000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-5614000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	127518000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-71004000	usd
	us-gaap	Net Income Loss NetIncomeLoss	123384000	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	831000	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	768000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2114000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6935000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	889000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	971000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3382000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-9826000	usd
	mnts	Fair Value Adjustment Of Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentOfFinancialInstrumentsSubjectToMandatoryRedemption	0	usd
	mnts	Fair Value Adjustment Of Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentOfFinancialInstrumentsSubjectToMandatoryRedemption	-209291000	usd
	mnts	Prepaid Launch Costs Impairment Charges PrepaidLaunchCostsImpairmentCharges	0	usd
	mnts	Prepaid Launch Costs Impairment Charges PrepaidLaunchCostsImpairmentCharges	9450000	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-121000	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	8564000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	11187000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1571000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	15350000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	901000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	677000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-328000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4357000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1873000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4546000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	92000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-4967000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	4829000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	851000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1071000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-908000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-115000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-23000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	5000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-71495000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-69897000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	618000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2835000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	7000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	30000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	16000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-641000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2852000	usd
	mnts	Proceeds From Issuance Of Financial Instruments Subject To Mandatory Redemption ProceedsFromIssuanceOfFinancialInstrumentsSubjectToMandatoryRedemption	0	usd
	mnts	Proceeds From Issuance Of Financial Instruments Subject To Mandatory Redemption ProceedsFromIssuanceOfFinancialInstrumentsSubjectToMandatoryRedemption	30853000	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	25000000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	517000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	278000	usd
	us-gaap	Proceeds From Repayment Of Loans By Employee Stock Ownership Plans ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans	190000	usd
	us-gaap	Proceeds From Repayment Of Loans By Employee Stock Ownership Plans ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	265000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6244000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	228421000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	6686000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	144000	usd
	mnts	Payment Of Warrant Issuance Costs PaymentOfWarrantIssuanceCosts	0	usd
	mnts	Payment Of Warrant Issuance Costs PaymentOfWarrantIssuanceCosts	31000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	40000000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	110000000	usd
	mnts	Payments Of Stock Issuance Costs Related To Private Placement PaymentsOfStockIssuanceCostsRelatedToPrivatePlacement	0	usd
	mnts	Payments Of Stock Issuance Costs Related To Private Placement PaymentsOfStockIssuanceCostsRelatedToPrivatePlacement	4416000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	128167000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	21285000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-78380000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	155672000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	160547000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23520000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	82167000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	179191000	usd
	mnts	Conversion Of Simple Agreement For Future Equity Issuance To Common Stock ConversionOfSimpleAgreementForFutureEquityIssuanceToCommonStock	0	usd
	mnts	Conversion Of Simple Agreement For Future Equity Issuance To Common Stock ConversionOfSimpleAgreementForFutureEquityIssuanceToCommonStock	136001000	usd
	mnts	Issuance Of Common Stock Warrant Liabilities Exercised IssuanceOfCommonStockWarrantLiabilitiesExercised	0	usd
	mnts	Issuance Of Common Stock Warrant Liabilities Exercised IssuanceOfCommonStockWarrantLiabilitiesExercised	6999000	usd
	mnts	Reclassification Of Deferred Offering Costs ReclassificationOfDeferredOfferingCosts	0	usd
	mnts	Reclassification Of Deferred Offering Costs ReclassificationOfDeferredOfferingCosts	2610000	usd
	mnts	Deferred Offering Costs Incurred During Noncash Or Partial Noncash Transaction Included In Accounts Payable And Accrued Expenses DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransactionIncludedInAccountsPayableAndAccruedExpenses	238000	usd
	mnts	Deferred Offering Costs Incurred During Noncash Or Partial Noncash Transaction Included In Accounts Payable And Accrued Expenses DeferredOfferingCostsIncurredDuringNoncashOrPartialNoncashTransactionIncludedInAccountsPayableAndAccruedExpenses	0	usd
	mnts	Warrant Liabilities Recognized Upon The Closing Of The Reverse Recapitalization WarrantLiabilitiesRecognizedUponTheClosingOfTheReverseRecapitalization	0	usd
	mnts	Warrant Liabilities Recognized Upon The Closing Of The Reverse Recapitalization WarrantLiabilitiesRecognizedUponTheClosingOfTheReverseRecapitalization	31225000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8501000	usd
	us-gaap	Accelerated Share Repurchases Adjustment To Recorded Amount AcceleratedShareRepurchasesAdjustmentToRecordedAmount	10000000	usd
	us-gaap	Accelerated Share Repurchases Adjustment To Recorded Amount AcceleratedShareRepurchasesAdjustmentToRecordedAmount	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1960000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1750000	usd
	us-gaap	Nature Of Operations NatureOfOperations	Nature of Operations<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Momentus Inc. (together with its consolidated subsidiaries “Momentus” or the “Company”) is a U.S. commercial space company that offers in-space infrastructure services, including in-space transportation, hosted payloads and in-orbit services. Momentus believes it can make new ways of operating in space possible with its planned in-space transfer and service vehicles that will be powered by an innovative water plasma-based propulsion system that is under development. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 4, 2022, the Company received a favorable determination from the Federal Aviation Administration (the “FAA”) of its application for payload review, which was the final regulatory milestone needed to support the Company’s inaugural flight of the Vigoride orbital service vehicle (Vigoride 3) in May 2022. The FAA favorable determination followed a license from the Federal Communications Commission (the “FCC”) received on April 28, 2022, and updates to existing licenses from the National Oceanic and Atmospheric Administration (the “NOAA”).</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 25, 2022, the Company launched its first demonstration flight of the Vigoride spacecraft (Vigoride 3) to low-earth orbit aboard the SpaceX Transporter-5 mission. In addition to Vigoride, Momentus used a second port on the same SpaceX mission to fly a third-party deployer from a partner company. On May 25, 2022, Momentus used the third-party deployer to place its first customer satellite in orbit. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 26, 2022, upon establishing two-way contact between the Vigoride spacecraft in low-earth orbit and a ground station on Earth, Momentus discovered that the Vigoride spacecraft had experienced certain anomalies after its launch, primarily relating to its deployable solar arrays, which provide power to the spacecraft and its subsystems. Since that time, the Company has been working to address the anomalies, identify root causes and pursue solutions to be implemented in advance of future missions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that the Vigoride spacecraft's deployable solar arrays, which are produced by a third party, and are folded and stowed during launch, did not operate as intended once in orbit. This resulted in low power and communications issues with the spacecraft. Meanwhile, the spacecraft's fixed, body-mounted solar panels appear to be working as intended and are providing some power to the spacecraft. The Company has been working closely with the producer of the solar arrays and has identified a mechanical issue as the root cause of the deployable arrays not operating as intended. The Company also believes that it has identified the root cause of the anomalies that it experienced with other spacecraft systems during the low-power state.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 28, 2022, Momentus was able to deploy two customer satellites from Vigoride 3 (of nine total customer satellites onboard Vigoride 3). The Company then continued efforts to deploy other customer satellites. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While Momentus initially established two-way communications with the Vigoride spacecraft, it has not been able to continue such two-way communication given the spacecraft's low-power state. Momentus has been using an unplanned frequency to work through the anomalies and applied for a 30-day Special Temporary Authority (“STA”) from the FCC to properly comply with the FCC’s radio frequency transmission requirements. On June 9, 2022, the Company received approval of a 30-day STA from the FCC as requested, which the FCC extended for an additional 30 days on July 13, 2022. Momentus has continued to apply for 30-day extensions for its STA, which the FCC has granted, most recently on October 20, 2022.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While Momentus has not been able to re-establish two-way communication with the Vigoride spacecraft, it has continued to broadcast commands to the spacecraft from ground stations on Earth, including commands to deploy customer satellites. Additionally, the Vigoride spacecraft is equipped with a mechanism designed to autonomously deploy customer satellites in the event that the spacecraft loses communications with ground stations. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, the Vigoride spacecraft deployed five additional customer satellites including two on July 17, 2022, two on July 29, 2022, and one at the end of August 2022. Momentus has now deployed a total of eight customer satellites in low-earth orbit, comprising seven satellites from Vigoride 3 and one satellite from the third-party deployer system.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While Momentus is continuing efforts to address the anomalies experienced by the Vigoride 3 spacecraft during its inaugural mission and to deploy the three remaining customer satellites, the Company’s level of confidence that it will be able to perform some planned operations of the vehicle on this test and demonstration mission has substantially declined. The Company is working to incorporate improvements identified during the current mission in advance of its planned follow-on missions. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company anticipates flying its second Vigoride vehicle to low-earth orbit on a third-party launch provider as early as December 2022. All future missions remain subject to the receipt of licenses and government approvals, and successful completion of our efforts to prepare our spacecraft for flight. The Company can offer no assurances that the vehicles that it plans to operate in future missions will be ready on time, or that they will operate as intended. Refer to “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors — We may not receive all required governmental licenses and approvals,” and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors — We are dependent on the successful development of our satellite vehicles and related technology,” </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under Part II, Item 1A: "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">," in this Form 10-Q and under Part I, Item 1A in our Annual Report on Form 10-K filed with the SEC on March 9, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background and Business Combination</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 12, 2021, the Company consummated a merger pursuant to certain Agreement and Plan of Merger, dated October 7, 2020, and as amended on March 5, 2021, April 6, 2021, and June 29, 2021 (the “Merger Agreement”), by and among Stable Road Acquisition Corp (“SRAC”), Project Marvel First Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of SRAC (the “First Merger Sub”), and Project Marvel Second Merger Sub, LLC, a Delaware limited liability company and a direct, wholly owned subsidiary of SRAC (the “Second Merger Sub”), pursuant to which the First Merger Sub merged with and into Momentus Inc., a Delaware corporation (“Legacy Momentus”), with Legacy Momentus as the surviving corporation of the First Merger Sub, and immediately following which Legacy Momentus merged with and into the Second Merger Sub, with the Second Merger Sub as the surviving entity (the “Business Combination”). In connection with the closing of the Business Combination (the “Closing”), the Company changed its name from Stable Road Acquisition Corp. to Momentus Inc., and Legacy Momentus changed its name to Momentus Space, LLC. </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Business Combination was accounted for as a reverse recapitalization under ASC Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ("ASC 805") in accordance with accounting principles generally accepted in the United States (“GAAP”). Under this method of accounting, SRAC, who was the legal acquirer, is treated as the “acquired” company for financial reporting purposes and Legacy Momentus is treated as the accounting acquirer. Accordingly, for accounting purposes, the Business Combination is treated as the equivalent of a capital transaction in which Legacy Momentus issued stock for the net assets of SRAC, with no goodwill or other intangible assets recorded, and Legacy Momentus’ financial statements became those of the Company. Reported shares and earnings per share available to holders of the Company’s Common Stock, prior to the Business Combination, have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination. See Note 3 for more information.</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Amended and Restated Certificate of Incorporation of the Company, at the Closing, each share of SRAC’s Class B Common Stock, par value $0.0001 per share (the “Class B Common Stock”), converted into one share of SRAC’s Class A Common Stock. After the Closing and following the effectiveness of the Second Amended and Restated Certificate of Incorporation of the Company, each share of Class A Common Stock was automatically reclassified, redesignated and changed into one validly issued, fully paid and non-assessable share of the Company’s Common Stock, par value $0.00001 per share (“Common Stock”), without any further action by the Company or any stockholder thereof. </span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Business Combination, SRAC’s units, public shares, and public warrants were listed on the Nasdaq under the symbols “SRACU,” “SRAC,” and “SRACW,” respectively. On August 13, 2021, the Company's Common Stock and public warrants began trading on the Nasdaq, under the symbols “MNTS” and “MNTSW,” respectively.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 7, 2020 and July 15, 2021, SRAC entered into subscription agreements with certain investors (the “PIPE Investors”) to which such investors collectively subscribed for an aggregate of 11,000,000 shares of the Company’s Common Stock at $10.00 per share for aggregate gross proceeds of $110.0 million (the “PIPE Investment”). The PIPE Investors were also granted an equal number of private warrants to purchase the Company’s Common Stock at $11.50 per share. The warrants were recorded as a derivative liability under ASC Topic 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (“ASC 815”) and the warrant liability was initially valued at $30.5 million. See Note 11 for more information. The PIPE Investment was consummated concurrently with the closing of the Business Combination.</span>
CY2022Q2	mnts	Number Of Customer Satellites Deployed NumberOfCustomerSatellitesDeployed	2	satellite
CY2022Q2	mnts	Number Of Customer Satellites NumberOfCustomerSatellites	9	satellite
CY2022Q2	mnts	Special Temporary Authority Period SpecialTemporaryAuthorityPeriod	P30D
CY2022Q2	mnts	Special Temporary Authority Period SpecialTemporaryAuthorityPeriod	P30D
CY2022Q2	mnts	Special Temporary Authority Period SpecialTemporaryAuthorityPeriod	P30D
CY2022Q2	mnts	Special Temporary Authority Extension Period SpecialTemporaryAuthorityExtensionPeriod	P30D
CY2022Q3	mnts	Number Of Additional Customer Satellites Deployed NumberOfAdditionalCustomerSatellitesDeployed	5	satellite
CY2022Q3	mnts	Number Of Additional Customer Satellites Deployed NumberOfAdditionalCustomerSatellitesDeployed	2	satellite
CY2022Q3	mnts	Number Of Additional Customer Satellites Deployed NumberOfAdditionalCustomerSatellitesDeployed	2	satellite
CY2022Q3	mnts	Number Of Additional Customer Satellites Deployed NumberOfAdditionalCustomerSatellitesDeployed	1	satellite
	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	8700000	usd
CY2022Q3	mnts	Number Of Customer Satellites Deployed In Low Earth Orbit NumberOfCustomerSatellitesDeployedInLowEarthOrbit	8	satellite
CY2022Q3	mnts	Number Of Internal Customer Satellites Deployed In Low Earth Orbit NumberOfInternalCustomerSatellitesDeployedInLowEarthOrbit	7	satellite
CY2022Q3	mnts	Number Of Third Party Customer Satellites Deployed In Low Earth Orbit NumberOfThirdPartyCustomerSatellitesDeployedInLowEarthOrbit	1	satellite
CY2022Q3	mnts	Number Of Customer Satellites Not Deployed NumberOfCustomerSatellitesNotDeployed	3	satellite
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	11000000	shares
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	110000000	usd
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	30500000	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2022, the Company reclassified certain cloud computing implementation costs from intangible assets to prepaid and other current assets, and other non-current assets to properly present the capitalized costs with their related subscription fees. In accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 350 Intangibles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company presents capitalized implementation costs for cloud computing arrangements within the same line item that the prepayment of these fees would be presented. The reclassification was determined to be immaterial and will be accounted for prospectively.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, we modified the presentation of cash flows related to the Business Combination. The presented impact of the issuance costs allocated to expense (described in Note 3), was moved into the issuance costs line. Additionally the presentation of capitalized issuance costs which were paid during the two quarters prior to the Business Combination was updated to present those expenditures within cash flows from financing activities, rather than cash flows from operations.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain other reclassifications have been made to the prior year’s financial statements to conform to the current year’s presentation. None of the reclassifications have changed the total assets, liabilities, stockholders’ equity (deficit), income, expenses or net losses previously reported.</span></div>
	us-gaap	Use Of Estimates UseOfEstimates	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Management bases its estimates on historical experience and on various other factors it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Accordingly, actual results could differ from those estimates. Significant estimates inherent in the preparation of the financial statements include, but are not limited to, accounting for useful lives of property, machinery and equipment, net, intangible assets, net, accrued liabilities, income taxes including deferred tax assets and liabilities, impairment valuation, stock-based awards, Simple Agreement for Future Equity (“SAFE”) notes, warrant liabilities and repurchase liabilities.
CY2022Q3	mnts	Deferred Fulfillment And Prepaid Launch Costs DeferredFulfillmentAndPrepaidLaunchCosts	6600000	usd
CY2021Q4	mnts	Deferred Fulfillment And Prepaid Launch Costs DeferredFulfillmentAndPrepaidLaunchCosts	3000000	usd
CY2021	mnts	Number Of Launch Agreements Terminated NumberOfLaunchAgreementsTerminated	2	agreement
	mnts	Prepaid Launch Costs Impairment PrepaidLaunchCostsImpairment	1800000	usd
	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	8700000	usd
	mnts	Other Impairment Of Ongoing Project OtherImpairmentOfOngoingProject	800000	usd
CY2021Q4	mnts	Deferred Fulfillment And Prepaid Launch Costs Recoveries DeferredFulfillmentAndPrepaidLaunchCostsRecoveries	2700000	usd
CY2022Q2	mnts	Number Of Customer Satellites Deployed NumberOfCustomerSatellitesDeployed	2	satellite
CY2022Q2	mnts	Number Of Customer Satellites NumberOfCustomerSatellites	9	satellite
CY2022Q2	mnts	Special Temporary Authority Period SpecialTemporaryAuthorityPeriod	P30D
CY2022Q3	mnts	Number Of Additional Customer Satellites Deployed NumberOfAdditionalCustomerSatellitesDeployed	5	satellite
CY2022Q3	mnts	Number Of Additional Customer Satellites Deployed NumberOfAdditionalCustomerSatellitesDeployed	2	satellite
CY2022Q3	mnts	Number Of Additional Customer Satellites Deployed NumberOfAdditionalCustomerSatellitesDeployed	2	satellite
CY2022Q3	mnts	Number Of Additional Customer Satellites Deployed NumberOfAdditionalCustomerSatellitesDeployed	1	satellite
CY2022Q3	mnts	Number Of Customer Satellites Deployed In Low Earth Orbit NumberOfCustomerSatellitesDeployedInLowEarthOrbit	8	satellite
CY2022Q3	mnts	Number Of Internal Customer Satellites Deployed In Low Earth Orbit NumberOfInternalCustomerSatellitesDeployedInLowEarthOrbit	7	satellite
CY2022Q3	mnts	Number Of Third Party Customer Satellites Deployed In Low Earth Orbit NumberOfThirdPartyCustomerSatellitesDeployedInLowEarthOrbit	1	satellite
CY2022Q3	mnts	Number Of Customer Satellites Not Deployed NumberOfCustomerSatellitesNotDeployed	3	satellite
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	1200000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12000	usd
CY2022Q2	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	14000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	600000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	600000	usd
CY2022Q3	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	14000	usd
CY2021Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	1400000	usd
	mnts	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	2400000	usd
CY2021	mnts	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	1600000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1200000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1600000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	50000	usd
CY2022Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	133000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	129000	usd
CY2022Q3	mnts	Contract With Customer Liability Revenue Recognized For Cancelled Contracts ContractWithCustomerLiabilityRevenueRecognizedForCancelledContracts	28000	usd
CY2022Q3	mnts	Contract With Customer Liability Revenue Recognized Due To Uncertainties ContractWithCustomerLiabilityRevenueRecognizedDueToUncertainties	101000	usd
CY2022Q3	mnts	Contract With Customer Liability Variable Consideration ContractWithCustomerLiabilityVariableConsideration	33000	usd
CY2021	mnts	Contract With Customer Liability Revenue Recognized For Cancelled Contracts ContractWithCustomerLiabilityRevenueRecognizedForCancelledContracts	300000	usd
CY2021	mnts	Reduction In Cost Of Goods And Services Sold ReductionInCostOfGoodsAndServicesSold	135000	usd
CY2022Q3	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents. The Company places its cash and cash equivalents in banks that management believes are creditworthy, however deposits may exceed federally insured limits.
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021Q3	mnts	Reverse Recapitalization Percentage Of Voting Interests Sold ReverseRecapitalizationPercentageOfVotingInterestsSold	1
CY2021Q3	mnts	Reverse Recapitalization Proceeds Received From Shareholders ReverseRecapitalizationProceedsReceivedFromShareholders	247300000	usd
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	110000000	usd
CY2021Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	137300000	usd
CY2021Q3	mnts	Reverse Recapitalization Public Investment ReverseRecapitalizationPublicInvestment	172500000	usd
CY2021Q3	mnts	Reverse Recapitalization Redemptions ReverseRecapitalizationRedemptions	35600000	usd
CY2021Q3	mnts	Reverse Recapitalization Impact On Shareholders Equity ReverseRecapitalizationImpactOnShareholdersEquity	8500000	usd
CY2021Q3	mnts	Reverse Recapitalization Proceeds Received In Cash From Operations ReverseRecapitalizationProceedsReceivedInCashFromOperations	400000	usd
CY2021Q3	mnts	Reverse Recapitalization Net Proceeds Received From Shareholders ReverseRecapitalizationNetProceedsReceivedFromShareholders	238800000	usd
CY2021Q3	mnts	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	27800000	usd
CY2021Q3	mnts	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	4800000	usd
CY2021Q3	mnts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.2467416
CY2021Q3	mnts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.2467416
CY2021Q3	mnts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.2467416
CY2021Q3	mnts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.2467416
CY2021Q3	mnts	Reverse Recapitalization Contingent Consideration Equity Non Transfer Period ReverseRecapitalizationContingentConsiderationEquityNonTransferPeriod	P6M
CY2021Q3	mnts	Reverse Recapitalization Contingent Consideration Equity Non Transfer Period Stock Price Trigger ReverseRecapitalizationContingentConsiderationEquityNonTransferPeriodStockPriceTrigger	12.00
CY2021Q3	mnts	Reverse Recapitalization Contingent Consideration Equity Non Transfer Period Threshold Trading Days ReverseRecapitalizationContingentConsiderationEquityNonTransferPeriodThresholdTradingDays	20	tradingday
CY2021Q3	mnts	Reverse Recapitalization Contingent Consideration Equity Non Transfer Period Threshold Consecutive Trading Days ReverseRecapitalizationContingentConsiderationEquityNonTransferPeriodThresholdConsecutiveTradingDays	30	tradingday
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	11000000	shares
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	110000000	usd
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	30500000	usd
CY2022Q3	mnts	Prepaid Launch Costs Current PrepaidLaunchCostsCurrent	3000000	usd
CY2021Q4	mnts	Prepaid Launch Costs Current PrepaidLaunchCostsCurrent	0	usd
CY2022Q3	mnts	Prepaid Research And Development Expense Current PrepaidResearchAndDevelopmentExpenseCurrent	3466000	usd
CY2021Q4	mnts	Prepaid Research And Development Expense Current PrepaidResearchAndDevelopmentExpenseCurrent	4870000	usd
CY2022Q3	mnts	Prepaid Insurance And Other Assets Current PrepaidInsuranceAndOtherAssetsCurrent	4473000	usd
CY2021Q4	mnts	Prepaid Insurance And Other Assets Current PrepaidInsuranceAndOtherAssetsCurrent	4562000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10939000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9431000	usd
CY2022Q3	mnts	Prepaid Launch Costs Noncurrent PrepaidLaunchCostsNoncurrent	3600000	usd
CY2021Q4	mnts	Prepaid Launch Costs Noncurrent PrepaidLaunchCostsNoncurrent	3000000	usd
CY2021Q2	mnts	Number Of Launch Service Agreements Terminated NumberOfLaunchServiceAgreementsTerminated	2	agreement
	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	8700000	usd
	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	8700000	usd
	mnts	Other Impairment Of Ongoing Project OtherImpairmentOfOngoingProject	800000	usd
CY2021Q4	mnts	Deferred Fulfillment And Prepaid Launch Costs Recoveries DeferredFulfillmentAndPrepaidLaunchCostsRecoveries	2700000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	1200000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12000	usd
CY2022Q2	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	14000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	600000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	600000	usd
	mnts	Prepaid Launch Costs Impairment PrepaidLaunchCostsImpairment	1800000	usd
CY2022Q2	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	14000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6647000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6656000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2314000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1827000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4333000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4829000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	200000	usd
	us-gaap	Depreciation Depreciation	700000	usd
CY2021Q3	us-gaap	Depreciation Depreciation	300000	usd
	us-gaap	Depreciation Depreciation	700000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	454000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	111000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	343000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	447000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	98000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	349000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	96000	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	37000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	12000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	49000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	49000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	49000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	49000	usd
CY2022Q3	mnts	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	135000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	343000	usd
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	11000000	usd
CY2021Q4	mnts	Lessee Operating Lease Number Of Leases Modified LesseeOperatingLeaseNumberOfLeasesModified	2	lease
CY2022Q3	mnts	Lessee Operating Lease Number Of Leases Modified LesseeOperatingLeaseNumberOfLeasesModified	1	lease
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	385000	usd
CY2021Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	435000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1229000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1306000	usd
CY2022Q3	us-gaap	Variable Lease Cost VariableLeaseCost	138000	usd
CY2021Q3	us-gaap	Variable Lease Cost VariableLeaseCost	147000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	429000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	442000	usd
CY2022Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	21000	usd
CY2021Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	22000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	8000	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	544000	usd
CY2021Q3	us-gaap	Lease Cost LeaseCost	585000	usd
	us-gaap	Lease Cost LeaseCost	1680000	usd
	us-gaap	Lease Cost LeaseCost	1757000	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y4M24D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.056
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	386000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1533000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1580000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1627000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1674000	usd
CY2022Q3	mnts	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	2026000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8826000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1261000	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	7565000	usd
CY2021Q3	mnts	Fair Value Adjustment To Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentToFinancialInstrumentsSubjectToMandatoryRedemption	26900000	usd
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3983000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4121000	usd
CY2022Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2715000	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3862000	usd
CY2022Q3	mnts	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	702000	usd
CY2021Q4	mnts	Accrued Research And Development Expenses Current AccruedResearchAndDevelopmentExpensesCurrent	1240000	usd
CY2022Q3	mnts	Accrued Offering Costs Current AccruedOfferingCostsCurrent	179000	usd
CY2021Q4	mnts	Accrued Offering Costs Current AccruedOfferingCostsCurrent	0	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	139000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	399000	usd
	mnts	Fair Value Adjustment To Financial Instruments Subject To Mandatory Redemption FairValueAdjustmentToFinancialInstrumentsSubjectToMandatoryRedemption	209300000	usd
CY2022Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	163000	usd
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	163000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7881000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9785000	usd
	mnts	Proceeds From Issuance Of Financial Instruments Subject To Mandatory Redemption ProceedsFromIssuanceOfFinancialInstrumentsSubjectToMandatoryRedemption	30900000	usd
CY2021Q3	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount SharesSubjectToMandatoryRedemptionSettlementTermsAmount	78000000	usd
CY2021Q3	mnts	Stock Issued During Period Value Conversion Of Safe Notes StockIssuedDuringPeriodValueConversionOfSAFENotes	136000000	usd
CY2021Q3	mnts	Common And Preferred Stock Shares Authorized CommonAndPreferredStockSharesAuthorized	270000000	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79772262	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q2	mnts	Reverse Recapitalization Release Of Proceeds From Shareholders Period Without Objection ReverseRecapitalizationReleaseOfProceedsFromShareholdersPeriodWithoutObjection	P15D
CY2021Q2	mnts	Proceeds From Sale Of Business And Other Capital Raising Transactions From Co Founders Minimum ProceedsFromSaleOfBusinessAndOtherCapitalRaisingTransactionsFromCoFoundersMinimum	2700000	usd
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79772262	shares
CY2021Q3	mnts	Common Stock Percentage Of Ownership After Reverse Recapitalization CommonStockPercentageOfOwnershipAfterReverseRecapitalization	1
CY2021Q2	mnts	Reverse Recapitalization Percentage Of Voting Interests Acquired ReverseRecapitalizationPercentageOfVotingInterestsAcquired	1
CY2021Q2	mnts	Reverse Recapitalization Initial Consideration Transferred To Each Co Founder ReverseRecapitalizationInitialConsiderationTransferredToEachCoFounder	1	usd
CY2021Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	50000000	usd
CY2021Q2	mnts	Reverse Recapitalization Proceeds Received From Shareholders ReverseRecapitalizationProceedsReceivedFromShareholders	247300000	usd
CY2021Q2	mnts	Reverse Recapitalization Payments To Co Founders ReverseRecapitalizationPaymentsToCoFounders	40000000	usd
CY2021Q2	mnts	Business Combination Initial Consideration Transferred To Co Founders BusinessCombinationInitialConsiderationTransferredToCoFounders	3	usd
CY2022Q3	mnts	Business Combination Contingent Consideration Liability To Co Founders BusinessCombinationContingentConsiderationLiabilityToCoFounders	10000000	usd
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4040360	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.27
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1064862	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.54
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1947970	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.27
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	313758	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.28
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2843494	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.12
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M24D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1965000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1402846	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.55
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y1M6D
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1364000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2843494	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.12
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y10M24D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1965000	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	700000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4900000	usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	10200000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	15600000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3289000	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3075000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8535000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11187000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3289000	usd
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3075000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8535000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11187000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-21298000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-5614000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-71004000	usd
	us-gaap	Net Income Loss NetIncomeLoss	123384000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-21298000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-5614000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-71004000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	123384000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82066795	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60589566	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81122541	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59873199	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4056805	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	302533	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82066795	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60589566	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81122541	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64232537	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.88
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.06
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.88
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.92
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31926058	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	24510729	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	27657880	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19897500	shares
CY2022Q3	us-gaap	Unrecorded Unconditional Purchase Obligation Due In Remainder Of Fiscal Year UnrecordedUnconditionalPurchaseObligationDueInRemainderOfFiscalYear	5963000	usd
CY2022Q3	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On First Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary	13100000	usd
CY2022Q3	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Second Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary	600000	usd
CY2022Q3	mnts	Unrecorded Unconditional Purchase Obligation To Be Paid After Year Three UnrecordedUnconditionalPurchaseObligationToBePaidAfterYearThree	0	usd
CY2022Q3	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	19663000	usd
CY2021Q2	mnts	Reverse Recapitalization Percentage Of Voting Interests Acquired ReverseRecapitalizationPercentageOfVotingInterestsAcquired	1
CY2021Q2	mnts	Reverse Recapitalization Initial Consideration Transferred To Each Co Founder ReverseRecapitalizationInitialConsiderationTransferredToEachCoFounder	1	usd
CY2021Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	50000000	usd
CY2021Q2	mnts	Reverse Recapitalization Proceeds Received From Shareholders ReverseRecapitalizationProceedsReceivedFromShareholders	247300000	usd
CY2021Q2	mnts	Reverse Recapitalization Payments To Co Founders ReverseRecapitalizationPaymentsToCoFounders	40000000	usd
CY2021Q2	mnts	Business Combination Initial Consideration Transferred To Co Founders BusinessCombinationInitialConsiderationTransferredToCoFounders	3	usd
CY2021Q2	mnts	Reverse Recapitalization Release Of Proceeds From Shareholders Period Without Objection ReverseRecapitalizationReleaseOfProceedsFromShareholdersPeriodWithoutObjection	P15D
CY2021Q2	mnts	Proceeds From Sale Of Business And Other Capital Raising Transactions From Co Founders Minimum ProceedsFromSaleOfBusinessAndOtherCapitalRaisingTransactionsFromCoFoundersMinimum	2700000	usd
CY2022Q3	mnts	Business Combination Contingent Consideration Liability To Co Founders BusinessCombinationContingentConsiderationLiabilityToCoFounders	10000000	usd
CY2022Q3	us-gaap	Legal Fees LegalFees	300000	usd
	us-gaap	Legal Fees LegalFees	1600000	usd
CY2021Q3	us-gaap	Legal Fees LegalFees	2200000	usd
	us-gaap	Legal Fees LegalFees	9600000	usd
CY2021Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0

Files In Submission

Name	View Source	Status
0001781162-22-000107-index-headers.html	Edgar Link	pending
0001781162-22-000107-index.html	Edgar Link	pending
0001781162-22-000107.txt	Edgar Link	pending
0001781162-22-000107-xbrl.zip	Edgar Link	pending
a20220930-ex311xceo.htm	Edgar Link	pending
a20220930-ex312xcfo.htm	Edgar Link	pending
a20220930-ex321xceo.htm	Edgar Link	pending
a20220930-ex322xcfo.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mnts-20220930.htm	Edgar Link	pending
mnts-20220930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
mnts-20220930_cal.xml	Edgar Link	unprocessable
mnts-20220930_def.xml	Edgar Link	unprocessable
mnts-20220930_lab.xml	Edgar Link	unprocessable
mnts-20220930_pre.xml	Edgar Link	unprocessable
mnts-20220930_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MNTS
Momentus Inc. Stock $mnts

2022 Q4 Form 10-Q Financial Statement

#000178116222000107 Filed on November 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNTS Momentus Inc. Stock $mnts

2022 Q4 Form 10-Q Financial Statement

#000178116222000107 Filed on November 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNTS
Momentus Inc. Stock $mnts